Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-CoV-2 Nucleocapsid antibody (Biotin)

This anti-SARS-CoV-2 Nucleocapsid antibody is a Mouse Monoclonal antibody detecting SARS-CoV-2 Nucleocapsid in . Suitable for SARS Coronavirus-2 (SARS-CoV-2).
Catalog No. ABIN7794973

Quick Overview for SARS-CoV-2 Nucleocapsid antibody (Biotin) (ABIN7794973)

Target

See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antibodies
SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Reactivity

  • 145
  • 37
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Host

  • 85
  • 29
  • 28
  • 8
  • 4
  • 3
  • 1
  • 1
Mouse

Clonality

  • 125
  • 18
  • 15
Monoclonal

Conjugate

  • 106
  • 23
  • 16
  • 8
  • 1
  • 1
  • 1
  • 1
  • 1
This SARS-CoV-2 Nucleocapsid antibody is conjugated to Biotin

Application

Please inquire

Clone

NP1-D4
  • Purpose

    Anti-SARS-CoV-2 Nucleocapsid (N) (Clone NP1-D4) Biotin

    Specificity

    Anti-SARS-CoV-2 Nucleocapsid, clone NP1-D4, specifically targets an epitope on the SARS-CoV-2 nucleocapsid protein. Furthermore, it is reported to bind to the RNA binding domain of the N protein. Antigen Distribution The nucleocapsid protein is expressed in the internal nucleocapsid of SARS-CoV-2. Background Coronavirus disease 2019 (COVID-19) is caused by the Coronaviridae family virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)1. SARS-CoV-2 has four structural proteins encoded by its single-stranded, positive-sense RNA genome the spike (S), envelope (E), membrane (M), and nucleocapsid (N) proteins2. The N protein is a highly conserved 46 kDa protein that shares 90 % homology with SARS-CoV3. The N protein has an N-terminal (NTD) and C-terminal domain (CTD), which bind to RNA and self-oligomerize, respectively4,5, forming a helical nucleocapsid structure within the viral envelope6. Other functions of the N protein included viral transcription, replication, and modulating cell signaling pathways7,8. The N protein is abundantly expressed during infection, and antibodies3,9 and memory T cells10,11 targeting the N protein have been identified in convalescent sera. Therefore, the N protein is a target in some vaccines and diagnostic assays12. The N protein also has therapeutic potential, as it evades RNAi-mediated antiviral responses13.

    Isotype

    IgG1
  • Restrictions

    For Research Use only
  • Concentration

    0.5 μg/mL

    Buffer

    This Biotinylated antibody is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1 % BSA and 0.09 % sodium azide as a preservative.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    This biotinylated antibody is stable when stored at 2-8°C. Do not freeze.
  • Target

    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

    Alternative Name

    SARS-CoV-2 Nucleocapsid (N)

    Target Type

    Viral Protein

    Background

    COV2-NP1-D4, SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein,
You are here:
Chat with us!